Terrie Curran - President and Chief Executive, Director at Phathom Pharmaceuticals, Inc.

Issuer-level insider activity

Role: President and Chief Executive, Director
Issuer ticker: PHAT on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Terrie Curran since 20 Sep 2025

Reported holdings for Terrie Curran in Phathom Pharmaceuticals, Inc.

Form 4 holding President and Chief Executive, Director

Phathom Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 360,465
Estimated value: $2,374,635
Report date: 21 Jan 2025
Price: $6.59
Ownership: Direct

Form 4 holding President and Chief Executive, Director

Phathom Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 3,840
Estimated value: $25,298
Report date: 21 Jan 2025
Price: $6.59
Ownership: By 401(k)

Form 4 holding President and Chief Executive, Director

Phathom Pharmaceuticals, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 342,500
Estimated value
Report date: 27 Feb 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Terrie Curran in Phathom Pharmaceuticals, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .